Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Datos Bibliográficos

ID23345491
AutoresPeter S Hendricks (University of Alabama at Birmingham), Christopher B Thorne (University of Alabama at Birmingham), C Brendan Clark (0000-0001-7004-4437, University of Alabama at Birmingham), David Coombs (0009-0005-9091-5515, University of Alabama at Birmingham), David W Coombs (University of Alabama at Birmingham), Matthew W Johnson (0000-0002-3741-6312, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA)
Año2015
Volumen29
Número3
Páginas280-288
Fecha de publicación2015-03-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Psychopharmacology (JOURNAL)
Identificadores de la revistaISSN: 0269-8811 • E-ISSN: 1461-7285
EditorialSAGE Publications (PUBLISHER • US)
DOI10.1177/0269881114565653
PMID25586402
OpenAlexW1997161439
IdiomaEN
Citas recibidas93
Referencias citadas52

Mental health problems are endemic across the globe, and suicide, a strong corollary of poor mental health, is a leading cause of death. Classic psychedelic use may occasion lasting improvements in mental health, but the effects of classic psychedelic use on suicidality are unknown. We evaluated the relationships of classic psychedelic use with psychological distress and suicidality among over 190,000 USA adult respondents pooled from the last five available years of the National Survey on Drug Use and Health (2008–2012) while controlling for a range of covariates. Lifetime classic psychedelic use was associated with a significantly reduced odds of past month psychological distress (weighted odds ratio (OR)=0.81 (0.72–0.91)), past year suicidal thinking (weighted OR=0.86 (0.78–0.94)), past year suicidal planning (weighted OR=0.71 (0.54–0.94)), and past year suicide attempt (weighted OR=0.64 (0.46–0.89)), whereas lifetime illicit use of other drugs was largely associated with an increased likelihood of these outcomes. These findings indicate that classic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics’ most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelics is warranted.

Distress · Environmental health · Logistic regression · Mental distress · Mental health · Odds · Odds ratio · Population · Psychiatry · Chemical synthesis and alkaloids · Clinical Psychology · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology

  • Recruitment discrimination of lifetime classic psychedelic users is unjustified

    Open Access•B A Korman•Journal of Psychedelic Studies•2023

  • Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers

    Open Access•B A Korman•Journal of Psychedelic Studies•2023

  • A double-edged sword

    Open Access•M Nordin, Jón Ingi Hlynsson et al.•Journal of Psychedelic Studies•2024

  • Race as a component of set and setting

    Open Access•Logan Neitzke-Spruill, Logan Neitzke‐Spruill•Journal of Psychedelic Studies•2019

  • Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics

    Open Access•James Sexton, Charles D Nichols et al.•Frontiers in Psychiatry•2020

  • Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests

    Open Access•Grant Jones, Maha Al‐Suwaidi et al.•Frontiers in Psychiatry•2023

  • Epidemiology of classic psychedelic substances

    Open Access•Tor-Morten Kvam, M V Uthaug et al.•Frontiers in Psychiatry•2023

  • Entheogenic Experience and Spirituality

    P G Johnstad•Method & Theory in the Study of…•2020

  • Farmakológiai biopolitikák (1. rész)

    Open Access•Ágnes Básthy, Zoltán Lengyel•Replika•2023

  • Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland

    Samuli Kangaslampi, Aino Hausen et al.•Journal of Psychoactive Drugs•2020

  • Cessation and reduction in alcohol consumption and misuse after psychedelic use

    Open Access•Albert Garcia‐Romeu, A K Davis et al.•Journal of Psychopharmacology•2019

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Ego-Dissolution and Psychedelics

    Open Access•Matthew M Nour, Lisa Evans et al.•Frontiers in Human Neuroscience•2016

  • Classic psychedelics

    Open Access•Matthew W Johnson, Peter S Hendricks et al.•Pharmacology & Therapeutics•2019

  • Long-term effects of psychedelic drugs

    Open Access•Jacob S Aday, Cayla M Mitzkovitz et al.•Neuroscience & Biobehavioral…•2020

  • Predicting Responses to Psychedelics

    Open Access•Eline C H M Haijen, Eline Haijen et al.•Frontiers in Pharmacology•2018

  • Psychedelic therapy for smoking cessation

    Open Access•T Noorani, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2018

  • The Challenging Experience Questionnaire

    Open Access•Frederick S Barrett, Matthew P Bradstreet et al.•Journal of Psychopharmacology•2016

  • Rebus and the Anarchic Brain

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Pharmacological Reviews•2019

  • Psychedelics and the essential importance of context

    Open Access•Robin L Carhart-Harris, Leor Roseman et al.•Journal of Psychopharmacology•2018

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin L Carhart-Harris, Mark Bolstridge et al.•The Lancet Psychiatry•2016

  • Psychedelics

    Open Access•David E Nichols•Pharmacological Reviews•2016

  • Psychedelics and workplace harm

    Open Access•Sean Matthew Vina, Amanda Layne Stephens•Frontiers in Psychiatry•2023

  • Toward a contextual psychedelic-assisted therapy

    Open Access•Jason B Luoma, Pablo Sabucedo et al.•Journal of Contextual Behavioral…•2019

  • The Ethic of Access

    Open Access•Morgan Campbell, M T Williams•Frontiers in Psychiatry•2021

  • Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder

    Open Access•Richard J Zeifman, A C Wagner•Journal of Contextual Behavioral…•2019

  • Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being

    Open Access•Charles L Raison, Rakesh K Jain et al.•Frontiers in Psychiatry•2022

  • Suicide Risk Among Cannabis, Heroin and Cocaine Users

    Open Access•Miguel Zacarías Pérez Sosa, Diego Vega et al.•International Journal of Mental…•2025

  • Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder

    Open Access•Shevaugn Johnson, Quentin Black et al.•International Journal of Mental…•2020

  • Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

    Open Access•Keri Mans, Hannes Kettner et al.•Frontiers in Psychiatry•2021

  • Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study

    Open Access•Saral Desai, Vidisha Jain et al.•Children•2022

  • Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the Covid-19 Confinement

    Open Access•Dóra Révész, Genís Ona et al.•Frontiers in Psychiatry•2021

  • The association between naturalistic use of psychedelics and co-occurring substance use disorders

    Open Access•Jonina Rabinowitz, Shaul Lev-Ran et al.•Frontiers in Psychiatry•2023

  • Psychedelic Mushrooms in the USA

    Open Access•Richard Matzopoulos, Robert Morlock et al.•Frontiers in Psychiatry•2022

  • Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential

    Open Access•Rita Kočárová, Jiřı́horáček et al.•Frontiers in Psychiatry•2021

  • Psychedelic Use and Mystical-Type Experiences are Associated With Greater Self-Compassion, Compassionate Love, and Life Satisfaction

    Open Access•Austin J Mallard, Matthew Broussard et al.•Journal of Humanistic Psychology•2026

  • Psychoanalyst attitudes towards psychedelic-assisted therapy

    Eli Kraiem, Marc J Diener et al.•Drugs Education Prevention and…•2025

  • Toward a positive psychology of psychoactive drug use

    K O St Arnaud•Drugs Education Prevention and…•2023

  • Intention-Setting Among Recreational Psychedelic Users

    Francis Low, M Earleywine•Journal of Psychoactive Drugs•2026

  • Association Between Lifetime Hallucinogen Use and Valvular Heart Disease

    Open Access•Kevin H Yang, Miranda Rasmussen et al.•Journal of Psychoactive Drugs•2026

  • Entheogenic Spirituality

    Open Access•P G Johnstad•International Journal for the…•2022

  • Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis

    Ansgar Rougemont-Bücking, Henrik Jungaberle et al.•Journal of Psychoactive Drugs•2019

  • A Public-Health-Based Vision for the Management and Regulation of Psychedelics

    Mark Haden, Brian Emerson et al.•Journal of Psychoactive Drugs•2016

  • Psychedelics, Personality and Political Perspectives

    Matthew M Nour, Lisa Evans et al.•Journal of Psychoactive Drugs•2017

  • Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use

    Mackenzie T Kiniry, Renee E Magnan et al.•Journal of Psychoactive Drugs•2025

  • The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

    Noah W Sweat, Larry W Bates et al.•Journal of Psychoactive Drugs•2016

  • Trends in the Top-Cited Articles on Classic Psychedelics

    David W Lawrence, Bhanu Sharma et al.•Journal of Psychoactive Drugs•2021

  • Healing Words

    Raymond Feng, Terence H W Ching et al.•Journal of Psychoactive Drugs•2023

  • Religion, Psychedelics, Risky Behavior, and Violence

    Sean Matthew Vina•Journal of Psychoactive Drugs•2024

  • Spiritual Benefit from Cannabis

    Frederick J Heide, Tai Chang et al.•Journal of Psychoactive Drugs•2021

  • Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities

    Open Access•Rafaelle L Lancelotta, Meghan A Dellacrosse et al.•Journal of Psychoactive Drugs•2025

  • Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia

    Nicolas G Glynos, Jennifer Pierce et al.•Journal of Psychoactive Drugs•2022

  • Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally

    Joyce Tsai, Laura Witte et al.•Journal of Psychoactive Drugs•2025

  • Exploring the Use of Psilocybin Therapy for Existential Distress

    Coryn E Mayer, Virginia Lebaron et al.•Journal of Psychoactive Drugs•2021

  • Magic Mushroom Use

    Lindsay Shaw, Kerri Rea et al.•Journal of Psychoactive Drugs•2022

  • Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users

    K O St Arnaud, Daphne Sharpe•Journal of Psychoactive Drugs•2022

  • Religious Social Integration, Psychedelics, and Psychological Distress

    Sean Matthew Vina•Journal of Psychoactive Drugs•2024

  • On the mushrooming reports of “quiet quitting”

    B A Korman•Journal of Psychoactive Drugs•2023

  • Ayahuasca and Public Health

    Genís Ona, Maja Kohek et al.•Journal of Psychoactive Drugs•2019

  • Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users

    Rafaelle L Lancelotta, Rafael L Lancelotta et al.•Journal of Psychoactive Drugs•2020

  • Unequal Healing

    Open Access•Sean Matthew Vina•Women & Therapy•2026

  • How psychedelic researchers’ self-admitted substance use and their association with psychedelic culture affect people’s perceptions of their scientific integrity and the quality of their research

    Open Access•Matthias Forstmann, Christina Sagioglou•Public Understanding of Science•2021

  • Plants Don’t Have a Culture to Appropriate

    Open Access•H Copes, Haley Copeland et al.•Sociology Compass•2025

  • Standing in the Gap

    Open Access•Tina Kempin Reuter, Fanicy Sears et al.•Anthropology of Consciousness•2025

  • Describing the Unspeakable

    Benjamin Dueck•Journal of Posthuman Studies•2020

  • Rural‐urban divide in risk perception of LSD

    Open Access•Melissa A Bradley, Daniel Grossman et al.•The Journal of Rural Health•2025

  • Hallucinations and Hallucinogens

    Open Access•José Carlos Bouso, Genís Ona et al.•Culture Medicine and Psychiatry•2023

  • Psychedelics and potential benefits in “healthy normals”

    Open Access•Gandy, Sam Gandy•Journal of Psychedelic Studies•2019

  • Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

    Open Access•Elmiro Argento, Elena Argento et al.•International Journal of Drug…•2022

  • Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States

    Open Access•Adam W Levin, Paul Nagib et al.•International Journal of Drug…•2022

  • Making “bad trips” good

    Open Access•Liridona Gashi, Sandberg et al.•International Journal of Drug…•2021

  • Møter med det hellige

    Open Access•Willy Pedersen•Tidsskrift for samfunnsforskning•2020

  • Classic Psychedelic Use and Mechanisms of Mental Health

    Open Access•Adèle Lafrance, Erin J Strahan et al.•Journal of Humanistic Psychology•2021

  • Self-Integration after Recreational Psychedelic Use

    Open Access•Franco Basaglia, James Rucker•Journal of Humanistic Psychology•2025

  • Of Roots and Fruits

    Open Access•David B Yaden, Khoa Le Nguyen et al.•Journal of Humanistic Psychology•2016

  • Psychological Distress Behavioral Patterns Among Latinos

    Open Access•Armando Barragán, Ann Marie Yamada et al.•Community Mental Health Journal•2018

  • Narratives of the mystical among users of psychedelics

    Open Access•Willy Pedersen, H Copes et al.•Acta Sociologica•2021

  • Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine

    Open Access•Genís Ona, Ali Berrada et al.•Transcultural Psychiatric…•2022

  • Psychedelic medicine at a crossroads

    Open Access•Gabriella Gobbi, Antonio Inserra et al.•Transcultural Psychiatric…•2022

  • Factors associated with psychedelic attitudes and usage among college students

    Open Access•W C Hwang, Yuhan Kong et al.•Journal of Psychedelic Studies•2025

  • Day trip to hell

    Open Access•P G Johnstad•Journal of Psychedelic Studies•2021

  • Beyond prohibition

    Open Access•Mark Haden, Sarah A Paschall et al.•Journal of Psychedelic Studies•2025

  • Psychosis and psychedelics

    Open Access•Phoebe Friesen•Transcultural Psychiatric…•2022

  • Macrodosing to microdosing with psychedelics

    Open Access•Ayse Ceren Kaypak, Aviad Raz et al.•Transcultural Psychiatric…•2022

  • Go ask Alice, when she's 10-feet tall

    Open Access•R Andrew Yockey, Keith A King et al.•Journal of Psychedelic Studies•2019

  • Psilocybin for depression

    Open Access•Kelley C O’donnell, Sarah E Mennenga et al.•Journal of Psychedelic Studies•2019

  • Psychedelic therapy in the Czech Republic

    Open Access•Zuzana Postránecká, Čestmír Vejmola et al.•Journal of Psychedelic Studies•2019

  • Psychedelic therapy as a complementary treatment approach for alcohol use disorders

    Open Access•Peter Eischens, W Leigh Atherton•Journal of Psychedelic Studies•2018

  • Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder

    Open Access•Rafael G Dos Santos, Flávia de Lima Osório et al.•Journal of Psychedelic Studies•2017

  • Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics

    Open Access•Natasha L Mason, Kim P C Kuypers•Journal of Psychedelic Studies•2018

  • A potential role for psilocybin in the treatment of obsessive-compulsive disorder

    Open Access•Edward Jacobs•Journal of Psychedelic Studies•2020

  • Minorities' Diminished Psychedelic Returns

    Open Access•Sean Matthew Vina•Journal of Racial and Ethnic…•2025

  • Protective and risk factors associated with comorbid mental health disorders and psychological distress among Latinx subgroups

    Armando Barragán, Ann Marie Yamada et al.•Journal of Human Behavior in the…•2020

  • Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction

    Open Access•Matthew W Johnson, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2014

  • Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

    Open Access•Robin Carhart‐Harris, Robin L Carhart-Harris et al.•Proceedings of the National…•2012

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Open Access•Katherine A Maclean, Matthew W Johnson et al.•Journal of Psychopharmacology•2011

  • Lysergic acid diethylamide (LSD) for alcoholism

    Open Access•Teri S Krebs, Pål-Ørjan Johansen•Journal of Psychopharmacology•2012

  • Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

    Open Access•Roland R Griffiths, William A Richards et al.•Psychopharmacology•2006

  • Good practice in the conduct and reporting of survey research

    K Kelley, Kristen D Kelley•International Journal for Quality…•2003

  • Development of a rational scale to assess the harm of drugs of potential misuse

    Open Access•David Nutt, David J Nutt et al.•The Lancet•2007

  • The role of religion and spirituality in mental health

    Samuel R Weber, Kenneth I Pargament•Current Opinion in Psychiatry•2014

  • Human hallucinogen research

    Open Access•MW Johnson, WA Richards et al.•Journal of Psychopharmacology•2008

  • Association of alcohol and drug use disorders and completed suicide

    Open Access•Holly C Wilcox, Kenneth R Conner et al.•Drug and Alcohol Dependence•2004

  • Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

    Charles S Grob, Alicia Danforth et al.•Archives of General Psychiatry•2011

  • Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

    Open Access•RR Griffiths, R R Griffiths et al.•Journal of Psychopharmacology•2008

  • Screening for serious mental illness in the general population with the K6 screening scale

    Open Access•R C Kessler, Jennifer Green et al.•International Journal of Methods…•2010

  • LSD-assisted psychotherapy for anxiety associated with a life-threatening disease

    Open Access•Peter Gasser, Katharina Kirchner et al.•Journal of Psychopharmacology•2015

  • Psychedelics and Mental Health

    Open Access•Teri Suzanne Krebs, Pål-Ørjan Johansen et al.•PLoS ONE•2013

  • Curiosity and Exploration

    Todd B Kashdan, Paul Rose et al.•Journal of Personality Assessment•2004

  • Suicide

    Open Access•Keith Hawton, Kees Van Heeringen•The Lancet•2009

  • Hallucinogens

    Open Access•David E Nichols•Pharmacology & Therapeutics•2004

  • The entropic brain

    Open Access•Robin L Carhart-Harris, Robert Leech et al.•Frontiers in Human Neuroscience•2014

  • Drug harms in the UK

    Open Access•David J Nutt, Leslie A King et al.•The Lancet•2010

  • Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

    Open Access•Peter Gasser, Dominique Holstein et al.•The Journal of Nervous and Mental…•2014

  • Psilocybin occasioned mystical-type experiences

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Psychopharmacology•2011

  • Short screening scales to monitor population prevalences and trends in non-specific psychological distress

    Open Access•R C Kessler, Gavin Andrews et al.•Psychological Medicine•2002

  • Suicide in the World

    Open Access•Peeter Värnik•International Journal of…•2012

  • Voice of the Psychonauts

    Leda Moro, Levente Móró et al.•Journal of Psychoactive Drugs•2011

  • Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner

    Michael Lyvers, Molly Meester•Journal of Psychoactive Drugs•2012

  • Values and Beliefs of Psychedelic Drug Users

    Melvin Lerner, Michael Lerner et al.•Journal of Psychoactive Drugs•2006

  • Personality, Suicidal Ideation, and Reasons for Living among Older Adults

    Daniel L Segal, Meghan A Marty et al.•The Journals of Gerontology…•2011

Obras citantes distintas93
Citas por año9,3
Intervalo de citas2016 - 2026 (11)
Velocidad de citacióncurrent
Altamente citadoNo
Tipos de citaNeutras: 83
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae